Literature DB >> 10543600

Semiconstrained total elbow arthroplasty in the context of treated previous infection.

K Yamaguchi1, R A Adams, B F Morrey.   

Abstract

Previous infection has been considered a strict contraindication to implantation or reimplantation of an elbow prosthesis. The purpose of this study was to investigate whether these patients can in fact be successfully treated with a prosthetic arthroplasty given previous treatment of the infection. Ten consecutive prosthetic arthroplasties performed in patients with documented infections in the elbow were retrospectively reviewed. Seven of the patients had infectious complications of total elbow arthroplasties that led to resection. Two patients had previous infections from septic joints and 1 from open reduction internal fixation. The median interval of time from infection treatment to final implant was 45 months (3.8 years). All arthroplasties were performed by the same surgeon with a modified Coonrad-Morrey, semiconstrained prosthesis. Patients were monitored for clinical signs of infection including radiographic and serologic studies and clinical evaluation based on the Mayo Elbow Performance Score. Mean surveillance was 4 years (range 2.8 to 5.4 years). Eight of the 10 cases have not shown signs of infection at the latest assessment. Two have had recurrent infections. The time interval from the original infection to latest implantation did not correlate with infection recurrence. Among those 8 without recurrent infection, 7 had excellent and 1 had satisfactory results according to the Mayo Elbow Performance Score. The recurrent infections were rated as failures. The average score was 32 before and 81 after surgery. The average pain score was 15 before surgery, and the average postoperative pain score was 40. Salvage of previously infected elbows with prosthetic arthroplasty can provide excellent results in a significant proportion of patients. Although the procedure offers superior functional outcomes compared with the alternative treatment options, it is technically demanding.

Entities:  

Mesh:

Year:  1999        PMID: 10543600     DOI: 10.1016/s1058-2746(99)90077-0

Source DB:  PubMed          Journal:  J Shoulder Elbow Surg        ISSN: 1058-2746            Impact factor:   3.019


  7 in total

1.  Implant sonication for the diagnosis of prosthetic elbow infection.

Authors:  Paschalis Vergidis; Kerryl E Greenwood-Quaintance; Joaquin Sanchez-Sotelo; Bernard F Morrey; Scott P Steinmann; Melissa J Karau; Douglas R Osmon; Jayawant N Mandrekar; James M Steckelberg; Robin Patel
Journal:  J Shoulder Elbow Surg       Date:  2011-12       Impact factor: 3.019

2.  Linked semi-constrained total elbow prosthesis in chronic arthritis: results of 18 cases.

Authors:  Maurizio Corradi; Marco Frattini; Bruno Panno; Silvio Tocco; Francesco Pogliacomi
Journal:  Musculoskelet Surg       Date:  2010-05

3.  Comparison of the hospital costs for two-stage reimplantation for deep infection, single-stage revision and primary total elbow arthroplasty.

Authors:  Eric R Wagner; Jeanine E Ransom; Hilal Maradit Kremers; Mark Morrey; Joaquin Sanchez-Sotelo
Journal:  Shoulder Elbow       Date:  2017-05-08

Review 4.  [Revision arthroplasty of the elbow].

Authors:  K J Burkhart; G Stein; E Skouras; L P Müller
Journal:  Unfallchirurg       Date:  2010-12       Impact factor: 1.000

Review 5.  Revision surgery for periprosthetic elbow infection: eradication rate, complications, and functional outcomes-a systematic review.

Authors:  Michele Mercurio; Davide Castioni; Orlando Cosentino; Filippo Familiari; Bruno Iannò; Giorgio Gasparini; Olimpio Galasso
Journal:  Arch Orthop Trauma Surg       Date:  2022-07-01       Impact factor: 3.067

6.  [Total elbow arthroplasty in sequelae of neglected osteoarthritis--report of a case].

Authors:  Abdelhalim El Ibrahimi; Mohammed Elidrissi; Mohammed Shimi; Abdelmajid Elmrini
Journal:  Pan Afr Med J       Date:  2011-08-22

7.  One- and two-stage surgical revision of infected elbow prostheses following total joint replacement: a systematic review.

Authors:  Setor K Kunutsor; Andrew D Beswick; Michael R Whitehouse; Ashley W Blom
Journal:  BMC Musculoskelet Disord       Date:  2019-10-22       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.